Reference
Luduena, R.F., et al., Tubulin structure and biochemistry.
Curr. Opin. Cell Biol. 4, 53-57, (1992)
abstract
Banerjee, A., Differential effects of colchicine and its B-ring modified analog MTPT on the assembly-independent GTPase activity of purified β-tubulin isoforms from bovine brain.
Biochem. Biophys. Res. Commun. 231, 698, (1997)
abstract
Suzuki, Y, Cell death, phagocytosis, and neurogenesis in mouse olfactory epithelium and vomeronasal organ after colchicine treatment. Ann. N.Y. Acad. Sci. 30, 252-254, (1998)
DeVincenzo, R., et al., Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.
Anticancer Drug Des. 13, 19-33, (1998)
abstract
Want, T.H., et al., Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways.
J. Biol. Chem. 273, 4928-4936, (1998)
abstract
Ceccatelli, S., et al., Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine.
Neuroreport 8, 3779-3783, (1997)
abstract
Andreu, J.M., et al., Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition.
Biochemistry 37, 8356-8368, (1998)
abstract
Jordan, A., et al., Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Med. Res. Rev. 18, 259-296, (1998)
abstract
Merck
Merck 13,2496
Beilstein
Beil. 14,IV,946
reference
Aldrich MSDS 1, 482:D / Corp MSDS 1 (1), 903:B / FT-IR 2 (2), 2980:D / FT-IR 1 (2), 361:C / FT-NMR 1 (2), 1374:C / IR-Spectra (3), 1072:F / IR-Spectra (2), 938:B / NMR-Reference 2 (2), 340:A / RegBook 1 (2), 2007:C / Sigma FT-IR 1 (2), 403:C / Structure Index 1, 320:D:5
Related Information
Links
Page Options
